This Best Buy Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Portfolio Pulse from Avi Kapoor
Top Wall Street analysts have upgraded their ratings for several companies, including Toll Brothers, Fate Therapeutics, Greif, Keurig Dr Pepper, and Best Buy. These upgrades come with increased price targets, indicating a positive outlook for these stocks.
June 17, 2024 | 1:51 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
UBS upgraded Best Buy from Neutral to Buy and raised the price target from $85 to $106. Shares closed at $87.21 on Friday.
The upgrade to Buy and the increased price target suggest a strong positive outlook for Best Buy, likely leading to a short-term price increase.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Piper Sandler upgraded Fate Therapeutics from Neutral to Overweight and increased the price target from $4 to $6. Shares closed at $3.61 on Friday.
The upgrade to Overweight and the higher price target indicate a strong positive outlook, likely leading to a short-term price increase for Fate Therapeutics.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
B of A Securities upgraded Greif from Neutral to Buy and raised the price target from $76 to $77. Shares closed at $60.73 on Friday.
The upgrade to Buy and the increased price target suggest a positive outlook for Greif, likely leading to a short-term price increase.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Goldman Sachs upgraded Toll Brothers from Sell to Neutral and raised the price target from $112 to $124. Shares closed at $119.32 on Friday.
The upgrade from Sell to Neutral and the increased price target suggest a more positive outlook for Toll Brothers, which could lead to a short-term price increase.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
Truist Securities upgraded Keurig Dr Pepper from Sell to Hold and raised the price target from $27 to $34. Shares closed at $34.04 on Friday.
The upgrade from Sell to Hold and the increased price target indicate a neutral to slightly positive outlook, likely leading to stable or slightly increased prices in the short term.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 80